LXRX vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 01, 2026

LXRX

61.2
AI Score
VS
LXRX Wins

ZBIO

56.8
AI Score

Investment Advisor Scores

LXRX

61score
Recommendation
BUY

ZBIO

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LXRX ZBIO Winner
Forward P/E 0 0 Tie
PEG Ratio -0.14 0 Tie
Revenue Growth 1572.1% -100.0% LXRX
Earnings Growth -63.4% 0.0% ZBIO
Tradestie Score 61.2/100 56.8/100 LXRX
Profit Margin -37.5% 0.0% ZBIO
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD LXRX

Relative Price Performance (Last 90 Days)

LXRX 1M: +0.0% · 3M: +3.1% ZBIO 1M: +4.2% · 3M: +62.8%

Current Technical Phase

LXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $2.30

ZBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (23.2% over 20 days), RSI 59

RSI (14): 58.5 · Price: $32.29

Fundamentals Snapshot

Metric LXRX ZBIO
Market Cap
Forward P/E -12.1 -6.7
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% -1.0%
Gross Margin 0.9% -212.5%
Operating Margin -38.4% -77.7%
EPS -0.14 -9.63
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.